Biotechco

 

  Hosted by     MSD Inventing For Life

BIOTECH COMPANY OF THE YEAR


This award recognises a European Biotech (drug discovery, pre-clinical, clinical, OTM therapeutic) company that has demonstrated a superior excellence in strategy, process, focus and execution to create significant value for patients, investors, employees and the broader life science community. 

Qualifying criteria

- Open to all Biotech therapeutic companies with European Headquarters
- Open to all biotech companies companies with a market capitalisation that is $10bn or less.
- Submission relates to activities achieved in the period between 1 September 2018 and 1 September 2019

Judges will be paying particular attention to:

- Targeting of unmet medical need / use of innovative approaches to pipeline development
- Pipeline progress through drug discovery / pre-clinical / clinical stages / market approval
- Closure of fundraises and strategic financing rounds
- Key stages of strategic development / partnerships
- Implementation of new technologies, processes for strategic advantage 
 
 
 
2019 WINNER
 
 
 
 
 
 
(L-R) Ellie Taylor, Emcee, Sean Marett, CBO, BioNTech, Ryan Richardson, VP, Corporate Development & Strategy, BioNTech, Sylke Maas, VP, Investor Relations & Business Strategy, BioNTech, James Ryan, VP, Legal and IP, BioNTech and Jill Richardson, Senior Director, Discovery Research, MSD.
 
 
 
2019 HIGHLY COMMENDED
 
 
 
 

2019 FINALISTS

 

AM-Pharma

AM-PHARMA, THE NETHERLANDS

Arvelle Therapeutics

ARVELLE THERAPEUTICS, SWITZERLAND

Astex Pharmaceuticals

ASTEX PHARMACEUTICALS, UNITED KINGDOM

Biontech

BIONTECH, GERMANY

Galapagos

GALÁPAGOS, BELGIUM

Hookipa Pharma

HOOKIPA PHARMA, AUSTRIA

Immatics Biotechnologies

IMMATICS BIOTECHNOLOGIES, GERMANY

Sanifit

SANIFIT, SPAIN

Scandinavian Biopharma

SCANDINAVIAN BIOPHARMA, SWEDEN

Shield Therapeutics

SHIELD THERAPEUTICS, UNITED KINGDOM

BUY TICKETS AND TABLES